Can Metformin Cause Rashes and What to Do?

Metformin can cause skin rashes, though most people taking the drug never experience them. Monitoring studies have found that roughly one in twenty metformin users develops some form of skin reaction, ranging from mild itching to rare blistering conditions. The rashes vary widely in appearance and severity, and figuring out that metformin is the culprit often takes longer than you would expect because skin problems are not the side effect most doctors think of first with this medication.

How Common Are Skin Reactions from Metformin

Metformin is far better known for gastrointestinal side effects like nausea and diarrhea, so skin reactions tend to fly under the radar. Adverse drug reaction monitoring in people with type 2 diabetes has found that itching and rashes occurred in about 5% of metformin users. That makes skin problems a minority side effect but not a trivially rare one.

A large Taiwanese study looking specifically at chronic urticaria, the persistent hives that last six weeks or more, found that metformin users developed the condition at a higher rate than matched non-users. About 3.3% of metformin users developed chronic urticaria during follow-up, compared with roughly 2% of non-users, translating to about a 56% higher risk after adjusting for other factors.¹ That is not an enormous absolute difference, but it is statistically solid and consistent enough to take seriously if you are on metformin and dealing with unexplained hives.

What These Rashes Look Like

There is no single “metformin rash.” The skin reactions reported in the medical literature span a surprisingly wide range of presentations, and knowing what to watch for can help you and your doctor connect the dots faster.

Chronic urticaria (hives): Raised, red, itchy welts that come and go over weeks. This is the most studied metformin-related skin reaction.
Fixed-drug eruption: Round, dark patches that appear in the same spot each time you take the drug. One well-documented case involved a woman who developed these lesions on her hands when she first started extended-release metformin, and the same pattern returned years later when the drug was restarted.²
Rosacea-like facial rash: Redness and bumps on the face that mimic rosacea. A reported case in a 29-year-old woman went through multiple misdiagnoses and failed treatments before the rash finally cleared when she stopped metformin on her own. Restarting the drug brought the rash right back.³
Generalized bullous fixed-drug eruption: Blistering skin lesions that can be widespread and painful. A reported case required treatment with strong immunosuppressive medications after stopping metformin.⁴
Leukocytoclastic vasculitis: Purplish, palpable spots on the lower legs caused by inflammation of small blood vessels. A case in a 33-year-old woman resolved after stopping metformin and recurred when the drug was reintroduced.⁵
Psoriasiform eruption: Red, scaly patches that resemble psoriasis. Along with leukocytoclastic vasculitis, this is one of only a handful of skin conditions formally documented as metformin-induced in the dermatology literature.⁶

The variety here is part of what makes diagnosis tricky. A doctor seeing hives might think allergies. One seeing facial redness might think rosacea. A scaly patch could look like psoriasis. Since metformin is not the first drug most clinicians associate with skin reactions, the connection can be missed for months or even years.

Does Dose or Duration Matter

Yes, and the relationship is striking. The same large study that identified the higher chronic urticaria risk found a clear dose-duration gradient. People with moderate cumulative metformin use had a modestly elevated risk, but those with the highest cumulative exposure, above 145 days per year, had about three times the risk of developing chronic urticaria compared to non-users.¹ The highest-use group also had a significantly elevated risk of being hospitalized for their hives.

This dose-response pattern is important for two reasons. First, it strengthens the case that metformin itself is driving the reaction rather than some confounding factor. When more drug exposure leads to more of a problem in a consistent, graded way, that is one of the stronger pieces of evidence for a causal relationship. Second, it means skin reactions can show up late. You might tolerate metformin for months and then develop hives in year two or three. If your doctor only considers drugs you recently started as suspects, metformin could be overlooked.

When a Rash Needs Urgent Attention

Most metformin-related rashes are uncomfortable but not dangerous. Hives and itching are annoying; they are not emergencies. But a few patterns warrant a prompt call to your doctor or a trip to urgent care.

Blistering is one red flag. Bullous fixed-drug eruptions involve fluid-filled blisters that can break open and leave raw, painful skin. One documented case of metformin-induced bullous eruption required treatment with oral steroids and cyclosporine, a powerful immunosuppressant, on top of stopping the drug.⁴ Any new blistering while taking metformin deserves same-day medical evaluation.

Purplish, raised spots on the legs could signal leukocytoclastic vasculitis, which involves small blood vessels and can sometimes affect the kidneys or other organs if left unchecked. And any rash accompanied by fever, joint pain, mouth sores, or difficulty breathing should be treated as a potential systemic drug reaction, regardless of what it looks like on the skin.

Bullous pemphigoid, a blistering autoimmune skin condition more commonly seen in older adults, has also been linked to metformin. An analysis of the FDA’s adverse event reporting database found a signal connecting non-sulfonylurea diabetes drugs, including metformin, to bullous pemphigoid.⁷ The condition has also been described in a published case report directly implicating metformin.⁸ Bullous pemphigoid causes large, tense blisters, often on the trunk, arms, and legs, and usually needs treatment with immunosuppressive therapy. If you are over 60 and develop widespread blistering on metformin, this is one condition your dermatologist should consider.

What to Do If You Suspect Metformin Is Causing a Rash

The single most important step is to tell your prescribing doctor. Do not stop metformin on your own without discussing it first, because uncontrolled blood sugar carries its own serious risks. But do not sit on the information either. A rash that keeps returning in the same location, hives that started after you began metformin, or any blistering should all be reported.

Your doctor will likely consider a dechallenge-rechallenge approach, which in plain language means stopping the drug to see if the rash goes away, then potentially restarting it to see if the rash comes back. This is the gold standard for confirming that a specific medication is causing a skin reaction. Multiple published case reports have used exactly this method to confirm that metformin was the trigger.² The rechallenge step is not always necessary or advisable, especially if the initial reaction was severe, but a clear improvement after stopping metformin is strong circumstantial evidence.

Formal allergy testing for metformin exists but is not routinely performed. In documented cases of metformin allergy presenting with skin lesions, the clinical history and the response to stopping the drug were enough to establish the connection.⁹ Skin-prick testing and patch testing can sometimes be done, but they are not standardized for metformin the way they are for penicillin, and a negative test does not necessarily rule out the drug as the cause.

If metformin is confirmed as the culprit, your doctor has options. Other diabetes medications can replace it. The choice depends on your blood sugar control, kidney function, insurance coverage, and other health conditions. Losing a first-line drug like metformin is inconvenient but not a crisis in modern diabetes management.

How Metformin Rashes Are Treated

The cornerstone of treatment is stopping the offending drug. For mild hives and itching, that alone may be enough, sometimes combined with an over-the-counter antihistamine to manage symptoms while the rash clears. Most mild metformin rashes resolve within days to a couple of weeks after discontinuation.

More serious reactions need more aggressive treatment. The case of generalized bullous fixed-drug eruption mentioned earlier was treated with topical clobetasol propionate (a potent steroid cream) plus oral prednisolone and cyclosporine.⁴ This level of intervention is reserved for blistering or widespread eruptions and would be managed by a dermatologist rather than a primary care doctor.

For chronic urticaria that persists even after metformin is stopped, treatment follows the standard approach for chronic hives: second-generation antihistamines as a first step, potentially escalating to higher doses or adding other medications if the hives do not settle. In some cases, chronic urticaria triggered by a drug can become self-sustaining even after the trigger is removed, though this is uncommon.

Could Something Else Be Causing the Rash

This is a question worth taking seriously, because people on metformin are often on multiple medications, and diabetes itself can affect the skin. Before pinning a rash on metformin, your doctor should consider some alternatives.

Other diabetes medications are well-known skin offenders. DPP-4 inhibitors, a class of drugs frequently prescribed alongside metformin, have been more strongly associated with bullous pemphigoid than metformin itself. If you take a combination pill or are on multiple diabetes drugs, teasing apart which one is responsible requires careful drug-by-drug evaluation.

Diabetes also raises the risk of skin infections. Fungal infections, in particular, are more common in people with elevated blood sugar. These can produce red, itchy, scaly patches that look a lot like a drug rash. Yeast infections in skin folds, athlete’s foot, and ringworm are all more prevalent in this population. Before concluding that metformin is causing a rash, it is worth having your doctor examine the affected area for signs of infection, especially if the rash is in warm, moist areas like skin folds or the feet.

Contact allergies, seasonal allergies, new laundry detergents, and other everyday triggers can also coincide with starting a new medication. The timing may look suspicious even when metformin is not at fault. This is exactly why the dechallenge-rechallenge method is so useful: it moves you from suspicion to something closer to certainty.

The Formulation Question

Metformin comes in immediate-release and extended-release formulations, and they contain different inactive ingredients like binders, coatings, and fillers. Some people who react to one formulation tolerate the other, which raises the possibility that the reaction is to an excipient rather than to metformin itself. Generic versions from different manufacturers can also differ in their inactive ingredients.

The case of fixed-drug eruption confirmed by multiple exposures is instructive here. The patient developed skin eruptions on extended-release metformin at a dose of 2,000 mg daily and had a similar reaction years earlier on the same formulation.² In her case, the reaction was tied to the drug itself, not the formulation. But if you develop a rash on one version of metformin, it is worth discussing a trial of a different formulation before abandoning the drug entirely. Switching from extended-release to immediate-release, or simply changing manufacturers, has resolved skin problems for some people, though published data on this is limited.

When Metformin Actually Helps the Skin

Here is an irony that catches people off guard: researchers are actively investigating metformin as a treatment for certain skin conditions. A review of the evidence found that metformin’s anti-inflammatory and anti-androgen properties make it a plausible candidate for treating acne, hidradenitis suppurativa (painful nodules in areas like the armpits and groin), and rosacea.¹⁰

This is not as contradictory as it sounds. A drug can trigger allergic or hypersensitivity reactions in a small subset of users while simultaneously having anti-inflammatory effects that benefit a different group. Aspirin is a good analogy: it reduces inflammation for most people, but it causes hives in a minority. The mechanism behind the rash (an immune system overreaction to the drug molecule) is completely different from the mechanism behind the therapeutic anti-inflammatory effect.

For people with polycystic ovary syndrome, metformin’s anti-androgen activity can improve hormonal acne. So if you are on metformin and your skin is getting better, that is also a real metformin effect. The drug’s relationship with the skin is genuinely two-sided, and which side you end up on depends on your individual immune response rather than on any property of the drug being inherently “good” or “bad” for skin.

Keeping Metformin in Perspective

Despite the range of skin reactions described above, metformin remains one of the safest and most effective first-line diabetes medications available. The rashes documented in the medical literature are mostly described as individual case reports precisely because they are rare enough to be worth publishing. The chronic urticaria association seen in larger data is real but modest in absolute terms: the difference between about 3 out of 100 users versus 2 out of 100 non-users developing chronic hives over years of follow-up.¹

The practical takeaway is awareness, not alarm. If you develop a new or worsening skin problem while on metformin, mention it to your doctor and make sure metformin is on the list of suspects. Most of the delayed diagnoses in the published literature happened because nobody thought to question a drug the patient had been taking for years. Knowing that metformin can cause rashes, even late-onset ones, puts you ahead of the curve.

1
PubMed Central. Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
2
PubMed Central. Metformin-Induced Fixed-Drug Eruption Confirmed by Multiple Exposures
3
PubMed Central. Rosacea-like facial rash related to metformin administration in a young woman
4
PubMed Central. Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review
5
PubMed Central. Rosacea-like facial rash related to metformin administration in a young woman – Section: Discussion
6
PubMed Central. Drug-Induced Generalized Skin Eruption in a Diabetes Mellitus Patient Receiving a Dipeptidyl Peptidase-4 Inhibitor Plus Metformin
7
PubMed Central. Bullous Pemphigoid and Diabetes medications: A disproportionality analysis based on the FDA Adverse Event Reporting System
8
International Journal of Scientific Reports. Metformin induced bullous pemphigoid, the first case
9
PubMed Central. Metformin allergy
10
PubMed Central. Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea